microfluidics
The project, called PCR-4-All, officially commenced Dec. 1 and will run through November 2026.
The device, which relies on magnets to move small amounts of fluid into different reaction chambers, can perform multiplexing and pooled testing.
Standard BioTools Partner Ascendas Genomics Gets Chinese Approval for MDx Systems
The companies partnered in 2017, striking a deal under which Ascendas would develop and commercialize the systems using Standard BioTools technology.
ScreenIn3D Platform Relies on Microfluidics, 3D Modeling to Monitor Cancer Treatment Efficacy
Premium
The firm's most recent research investigates how the platform could be applied to CAR-T therapy for solid tumors.
The Charlottesville, Virginia-based company expects to add an infectious disease test menu to its system using its proprietary extraction process.